Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to: Letter to the Editor Concerning "Financial Toxicity Among Survivors of Extremity and Pelvic Sarcoma: A Retrospective Study".

Annals of surgical oncology·2026

Same author

Cryoablation versus Radiofrequency Ablation for the Treatment of Osteoid Osteoma.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Age- and level-dependent glucose metabolism in the lumbar spine and preliminary associations with severe low back pain: A retrospective FDG PET imaging study.

Osteoarthritis and cartilage·2026

Same author

Exploring Best Practices for Screening for Financial Toxicity in Patients With Sarcoma: A Single-Institution Study.

JCO oncology practice·2026

Same author

Rethinking Residency Selection: Beyond Test Scores and Prestige.

The Journal of bone and joint surgery. American volume·2026

Same author

Exposure to PFOA and GenX elicits cell typespecific impacts on p53 and TGF-β signaling pathways.

Molecular biology reports·2026

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

ATRX and Its Prognostic Significance in Soft Tissue Sarcoma.

Mark M Cullen¹, Warren Floyd², Bobby Dow³

¹Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.

|May 14, 2024

Summary

This summary is machine-generated.

High ATRX expression indicates better survival in soft tissue sarcoma (STS). This finding suggests ATRX is a positive prognostic indicator for overall and metastasis-free survival in STS patients.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

Related Experiment Videos

Last Updated: Jun 22, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

Area of Science:

Oncology
Molecular Pathology

Background:

The association between ATRX (Alpha-thalassemia/mental retardation syndrome X-linked) and aggressive sarcoma phenotypes is increasingly recognized.
Understanding prognostic markers is crucial for effective soft tissue sarcoma (STS) management.

Purpose of the Study:

To retrospectively evaluate ATRX as a prognosticator in soft tissue sarcoma.
To determine the association between ATRX expression and patient survival outcomes.

Main Methods:

A retrospective study of 128 sarcomas from a single institution.
Immunohistochemical staining for ATRX expression.
Prognostic significance evaluated using Kaplan-Meier curves and Cox regression analysis in a cohort of 68 primary STS.

Main Results:

High ATRX expression was a significant positive prognostic indicator for overall survival (HR: 0.38, P=0.02).
High ATRX expression also predicted improved metastasis-free survival (HR: 0.49, P=0.05).
These findings were consistent in both univariate and multivariate analyses.

Conclusions:

High ATRX expression is a favorable prognostic marker for overall and metastasis-free survival in STS patients.
Findings align with studies in osteosarcoma, suggesting ATRX loss may drive more aggressive phenotypes.
Further prospective studies are needed to confirm the prognostic value of ATRX in STS.